Bharat Biotech’s COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase-2 and phase-3 clinical trials on those aged between two to 18 years, official sources said.
Covaxin Recommended For Next Phase Of Trials For 2-18 Age Group: Report
Similar Articles
Odisha: Sabar tribal families postpone demonstration
Cuttack: 872Â Sabar Tribal Families of Dhenkanal District led by State President Er Debashisha Hota postponed their demonstration at Cuttack on March 30, 2022,...
Bihar teachers demonstrate to release stopped salary
Patna: Teachers of Bihar on March 23, 2022, demonstrated at Gardanibagh here to release their stopped salary for the last 3 years. NIOS DELED Teachers’...
